depakine 125ml syrup is a medication that primarily acts by increasing the availability of gamma-aminobutyric acid (GABA) in the brain. It achieves this through various mechanisms, including inhibiting GABA transaminase, an enzyme responsible for breaking down GABA, thus enhancing its inhibitory effects on neuronal excitability. Furthermore, valproic acid stabilizes neuronal membranes and modulates ion channels, particularly sodium channels, which decreases high-frequency firing of neurons associated with seizure activity. These actions collectively contribute to the medication's effectiveness in controlling seizures and managing mood disorders.
Indications and Uses of depakine 125ml syrup
- Management of generalized seizures, including tonic-clonic seizures.
- Control of focal seizures with or without secondary generalization.
- Adjunct therapy for patients with epilepsy.
- Prophylaxis of migraine headaches.
- Treatment of bipolar disorder episodes.
Side Effects of depakine 125ml syrup
- Nausea and vomiting.
- Drowsiness or sedation.
- Weight gain.
- Hair loss.
- Liver function abnormalities.
- Pancreatitis.
- Potential for teratogenic effects in pregnancy.
Storage and Handling
Store depakine 125ml syrup at room temperature, away from direct light and moisture. Keep out of reach of children. Do not freeze.
Patient Advice and Precautions
Patients should be counseled to adhere strictly to prescribed regimens and report any unusual symptoms, particularly signs of liver dysfunction or pancreatitis. Regular monitoring of liver function tests and blood levels of valproic acid may be necessary. Pregnant women or those planning to become pregnant should discuss potential risks with their healthcare provider, as valproic acid is associated with birth defects.
Scientific Degree: pharmacist
Country: Egypt
Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer
A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.
Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.
Published Date: 05 January 2025
Source 1 :
Drugs Valproic acid
you should ask your doctor before taking this medicine